Delivery Order SPE2DB20D3101-SPE2DB22FJ8N8
Award Date 5/17/22
Potential Completion Date 5/18/22
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,141.48 firm fixed-price delivery order is for the supply of 4,563,337,095 units of the pharmaceutical drug Divalproex Sodium Extended-Release 500 mg Tablets. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,150.56 firm fixed-price contract is for the supply of 4,568,239,064 units of the prescription medication Divalproex Sodium Extended-Release 500 mg Tablets. The award is not set aside and represents an order under Amerisourcebergen's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,049.92, is for the delivery of Divalproex Sodium Extended-Release (ER) 500 mg tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of June 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Divalproex Sodium Extended-Release 500 mg tablets. The fixed-price contract, valued at $1,011.15, has an ultimate completion date of October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medication supplies to support federal healthcare programs and facilities, including military treatment centers. This contract is part of a...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Divalproex Sodium Extended-Release 500 mg tablets (500-count) with a ceiling value of $1,728.07. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, awarded on September 16, 2025, with no set-aside designation. The contract represents a competitive award under DLA's pharmaceutical procurement processes and will be performed at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product Divalproex Sodium Extended Release 500 mg Tablets, Unbreakable Dose, in packages of 80, with a potential value of $1,105.76 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,328.59 firm fixed-price delivery order covers the supply of DEPAKOTE DR 250 MG TABLET 100S, a medication used to treat certain types of seizures. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,182.62 firm fixed-price delivery order contract is for the supply of Depakote DR 250 mg tablets. The contract has an ultimate completion date of August 24, 2022 and was awarded on August 23, 2022. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,161.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of DEPAKOTE ER 250 MG TABLET 100S, with an ultimate completion date of October 29, 2024. The contract type is Firm Fixed Price, and no set-aside designation was used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...